Nature Research

SHERPA: Unknown

People

  1. Ladanyi
    Ladanyi
  2. Arcila
    Arcila
  3. Drilon
    Drilon
  4. Jungbluth
    Jungbluth
  5. Abdel-Wahab
    Abdel-Wahab
  6. Antonescu
    Antonescu
  7. Berger
    Berger
  8. Chiang
    Chiang
  9. Diamond
    Diamond
  10. Dogan
    Dogan

Groups

  1. Department of Medicine (7)
  2. Early Drug Development Service (7)
  3. GSK Faculty (7)
  4. Solid Tumor Oncology Division (7)
  5. Tow Center for Developmental Oncology (TCDO) (6)
  6. Department of Pathology and Laboratory Medicine (5)
  7. Human Oncology and Pathogenesis Program (5)
  8. Thoracic Oncology (3)
  9. Center for Hematologic Malignancies (1)
  10. Center for Molecular Imaging and Biotechnology (CMIB) (1)
Search Within
  1. "Early Drug Development Service"
Formats
  1. Meeting Abstract (5)
  2. Journal Article (1)
  3. Review (1)
Groups
  1. Department of Medicine (7)
  2. Early Drug Development Service (7)
  3. GSK Faculty (7)
  4. Solid Tumor Oncology Division (7)
  5. Tow Center for Developmental Oncology (TCDO) (6)
  6. Department of Pathology and Laboratory Medicine (5)

More Groups

People
  1. David Hyman (7)
  2. Marc Ladanyi (5)
  3. Ahmet Zehir (4)
  4. Jaclyn Hechtman (4)
  5. Achim Jungbluth (3)
  6. Alexander Drilon (3)

More People

Years
  1. 2020 (2)
  2. 2019 (1)
  3. 2018 (1)
  4. 2017 (2)
  5. 2015 (1)
Publications
  1. Modern Pathology (6)
  2. Nature Cancer (1)

Results (7)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Discovery through clinical sequencing in oncology
    Review

    Donoghue, M. T. A.; Schram, A. M.; Hyman, D. M.; Taylor, B. S.
    Nature Cancer (2020)

    Fulltext@MSK | Save
  • NTRK fusion detection across multiple assays and 33,997 cases: Diagnostic implications and pitfalls
    Journal Article

    Solomon, J. P.; Linkov, I.; Rosado, A.; Mullaney, K.; Rosen, E. Y.; Frosina, D.; Jungbluth, A. A.; Zehir, A.; Benayed, R.; Drilon, A.; more...
    Modern Pathology (2020)

    Fulltext@MSK | Save
  • Novel activating mutations in CSF1R and additional kinases with therapeutic implications in histiocytic neoplasms
    Meeting Abstract

    Durham, B.; Picarsic, J.; Lopez-Rodrigo, E.; Hyman, D.; Diamond, E.; Abdel-Wahab, O.
    Modern Pathology (2019)

    Fulltext@MSK | Save
  • NTRK fusions define a novel uterine sarcoma subtype with features of fibrosarcoma
    Meeting Abstract

    Chiang, S.; Cotzia, P.; Hyman, D.; Drilon, A.; Hechtman, J.; Jungbluth, A.; Murali, R.; Soslow, R.; Oliva, E.; Benayed, R.; more...
    Modern Pathology (2018)

    Fulltext@MSK | Save
  • Pan-TRK IHC is an efficient and reliable screening assay for targetable NTRK fusions
    Meeting Abstract

    Hechtman, J. F.; Drilon, A.; Hyman, D. M.; Zehir, A.; Dogan, S.; Arcila, M. E.; Ladanyi, M.; Benayed, R.; Jungbluth, A.
    Modern Pathology (2017)

    Fulltext@MSK | Save
  • Genomic landscape and clinical features of carcinomas with ERBB2 S310 extracellular domain mutations
    Meeting Abstract

    Desmeules, P.; Zehir, A.; Hyman, D. M.; Arcila, M. E.; Ladanyi, M.
    Modern Pathology (2017)

    Fulltext@MSK | Save
  • Comprehensive assessment of RAS/RAF mutation status and identification of alternative targetable driver alterations in RAS/RAF wild type colorectal carcinoma using a hybrid capture-based next-generation sequencing assay
    Meeting Abstract

    Hechtman, J.; Zehir, A.; Cheng, D.; Shia, J. R.; Solit, D.; Yaeger, R.; Hyman, D.; Arcila, M.; Berger, M.; Ladanyi, M.; more...
    Modern Pathology (2015)

    Fulltext@MSK | Save

    • Nature Research – authorized name for: